Atrioventricular synchronous leadless pacing: Micra AV

Abstract

Since the arrival of leadless pacemakers (LPs), they have become a cornerstone in remedial treatment of bradycardia and atrioventricular (AV) conduction disorders, as an alternative to transvenous pace-makers. Even though clinical trials and case reports show indisputable benefits of LP therapy, they also bring some doubts. Together with the positive results of the MARVEL trials, AV synchronization has become widely available in LPs, presenting a significant development in leadless technology. This review presents the Micra AV, describes major clinical trials, and introduces the basics of AV synchronicity obtained with the Micra AV and its unique programming options. (Cardiol J 2024; 31, 1: 147–155).